Diabetes, Drug Pricing and Pharmaceutical Companies

STAT+: Warren urges FTC to probe deal that would give Novo Nordisk control of some Catalent plants

STAT

OCTOBER 10, 2024

billion deal in which Novo Nordisk’s parent foundation would acquire Catalent, a leading contract drug manufacturer, over concerns the acquisition would give the pharmaceutical company an unfair advantage in the burgeoning market for drugs used to treat obesity and diabetes.

Packaging

Packaging Diabetes Pharmaceutical Companies Pharmaceutical Companies

STAT+: Pharmalittle: FDA approves Pfizer’s RSV vaccine for newborns; Boehringer sues over IRA

STAT

AUGUST 22, 2023

German drugmaker Boehringer Ingelheim is the latest pharmaceutical company to sue the federal government over a law that would allow Medicare to negotiate certain drug prices, Reuters reports. Continue to STAT+ to read the full story…

Vaccines

Vaccines Drug Pricing Diabetes Pharmaceutical Companies

Mapping the crisis: How data can help fix America’s growing pharmacy deserts

pharmaphorum

JUNE 12, 2025

Skip to main content Thursday 12 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Health and Personal Care Stores

Health and Personal Care Stores Diabetes Pharmaceutical Companies Pharmaceutical Companies

Navigating the Rising Costs of Brand-Name Drugs

Digital Pharmacist

MARCH 19, 2024

From sweeping federal legislation aimed at reigning in costs to the unexpected maneuvers of drug manufacturers, the effects of these changes reverberate throughout the healthcare system. The Dynamics of Increasing Drug Prices The escalation of drug prices is a multifaceted issue, with various factors contributing to its rise.

Drug Pricing

Drug Pricing Diabetes Pharmaceutical Companies Pharmaceutical Companies

Is India capable of ensuring equitable access to biopharmaceuticals?

Express Pharma

SEPTEMBER 6, 2023

According to the World Health Organisation (WHO), an estimated two billion people across the world do not have access to essential medicines for life threatening diseases like cancer, AIDS and even autoimmune diseases like Type 1 diabetes. The post Is India capable of ensuring equitable access to biopharmaceuticals?

Insurance Coverage and Processing

Insurance Coverage and Processing Biosimilars Generic Medicine Drug Pricing

STAT+: FTC issues warnings on ‘junk’ patent listings for Ozempic and other drugs

STAT

APRIL 30, 2024

Federal Trade Commission expanded its campaign against pharmaceutical companies for filing what it calls “junk” patent listings pertaining to 20 different brand-name treatments for asthma, COPD, diabetes and weight loss, including the blockbuster Ozempic diabetes medicine sold by Novo Nordisk.

Diabetes

Diabetes Pharmaceutical Companies Pharmaceutical Companies Drug Pricing

STAT+: Bernie Sanders may have reached the limits of his pharma pressure campaign

STAT

MAY 20, 2024

For more than a year, Sanders has used his perch atop the Senate health committee to haul the CEOs of pharmaceutical companies that make insulin, vaccines, and more before the panel with progressively more ambitious demands related to their pricing. Sanders (I-Vt.)

Diabetes

Diabetes Pharmaceutical Companies Pharmaceutical Companies Vaccines

Senator floats new models to manage costs of weight loss drugs like Ozempic

STAT

NOVEMBER 9, 2023

Seventy percent of Americans could qualify for these medicines.

Diabetes

Diabetes Pharmaceutical Companies Pharmaceutical Companies Drug Pricing

6 Key Factors Influencing the Pharmaceutical Industry

PharmaShots

MAY 9, 2023

Sit back and relax, while the article unfolds before you, the magic model that is certain to revamp your company Achieving economic sustenance and ensuring smooth sailing even in unfavorable situations are two common dreams that every pharmaceutical company shares.

Pharmaceutical Companies

Pharmaceutical Companies Pharmaceutical Companies Drug Development Drug Pricing

STAT+: Pharmalittle: Next big hope for Alzheimer’s might not help most Black patients; drugmakers ask Supreme Court to toss terrorism-support ruling

STAT

JULY 6, 2023

Advertisements eviscerating and glorifying pharmacy benefit managers have been around for years, but have intensified over the past three months as Congress scrutinizes the role these middlemen play in shaping high prescription drug prices , STAT tells us.

Drug Pricing

Drug Pricing Vaccines Diabetes Pharmaceutical Companies

Understanding Recent Changes to 505(b)(2) Drugs and Reimbursement

Pharmacy Times

JUNE 23, 2025

This pathway’s expanded use and shifting Centers for Medicare & Medicaid Services (CMS) policies are reshaping reimbursement practices and therapeutic equivalence standards for 505(b)(2) drugs. Based on this ruling, 505(b)(2) drugs that are not therapeutically interchangeable should be considered sole-source drugs.

Pharmacy Technician

Pharmacy Technician Compounding Pharmacies Dosage Hospitals

Transparency, social change can help pharma regain the public’s trust

pharmaphorum

APRIL 27, 2022

Especially, women tend to have more distrust in pharmaceutical companies. Working on a diabetes drug? Look at how your drug pricing and access impact certain demographics and then work from there. Interestingly, the same report found that trust is a positive determinant of good health behaviours (e.g.,

Vaccines

Vaccines Drug Pricing Diabetes Pharmaceutical Companies

STAT+: Pharmalittle: We’re reading about Amgen suing Colorado over drug price caps, abortion pills, and more

STAT

MARCH 26, 2024

The bill would ban Chinese biotech companies “of concern” — and any pharmaceutical companies that work with them — from getting federal contracts in a bid to ensure national security. Meanwhile, the Biosecure Act, designed to reduce U.S.

Drug Pricing

Drug Pricing Insurance Coverage and Processing Diabetes Pharmaceutical Companies

Amid sector disruption, biotech must focus on 'fundamentals'

pharmaphorum

JUNE 18, 2025

Skip to main content Wednesday 18 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views (..)

Diabetes

Diabetes Pharmaceutical Companies Pharmaceutical Companies Immunity

Biden and Trump are fighting to claim credit for $35 insulin. It was actually a pharma giant’s idea

STAT

JUNE 13, 2024

But the credit should actually go to a giant pharmaceutical company — just the type that both men claim to have challenged. WASHINGTON — Both President Biden and former President Trump love to claim credit for getting more Americans $35 insulin. Read the rest…

Pharmaceutical Companies

Pharmaceutical Companies Pharmaceutical Companies Drug Pricing Diabetes

Makary: Drugs don’t have to take 10 years to get to market

pharmaphorum

JUNE 17, 2025

Skip to main content Tuesday 17 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes

Diabetes Pharmaceutical Companies Pharmaceutical Companies Drug Pricing

STAT+: Pharmalittle: We’re reading about Medicare plans to negotiate obesity-drug prices, a Novartis 340B lawsuit, and more

STAT

JANUARY 17, 2025

Medicare officials announced plans to negotiate the prices of blockbuster diabetes and weight loss drugs Ozempic and Wegovy, further complicating big decisions the Trump administration will have to make about how to cover the medications, STAT writes. Eli Lilly makes rival diabetes and weight loss drugs Mounjaro and Zepbound.

Drug Pricing

Drug Pricing Diabetes Hospitals Pharmaceutical Companies

FDA clears Nuvation lung cancer drug, setting up battle with Bristol Myers and Roche

BioPharma Dive

JUNE 11, 2025

Published June 11, 2025 Ben Fidler Senior Editor post share post print email license The FDA on June 11, 2025 approved Nuvation's Ibtrozi for ROS1-positive non-small cell lung cancer. Informa PLCs registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. TechTarget, Inc.s registered office is 275 Grove St.

Drug Pricing

Drug Pricing Immunity Immunization Drug Development

Pharmacist Digest

STAT+: Warren urges FTC to probe deal that would give Novo Nordisk control of some Catalent plants

STAT+: Pharmalittle: FDA approves Pfizer’s RSV vaccine for newborns; Boehringer sues over IRA

Trending Sources

Mapping the crisis: How data can help fix America’s growing pharmacy deserts

Navigating the Rising Costs of Brand-Name Drugs

Is India capable of ensuring equitable access to biopharmaceuticals?

STAT+: FTC issues warnings on ‘junk’ patent listings for Ozempic and other drugs

STAT+: Bernie Sanders may have reached the limits of his pharma pressure campaign

Senator floats new models to manage costs of weight loss drugs like Ozempic

6 Key Factors Influencing the Pharmaceutical Industry

STAT+: Pharmalittle: Next big hope for Alzheimer’s might not help most Black patients; drugmakers ask Supreme Court to toss terrorism-support ruling

Understanding Recent Changes to 505(b)(2) Drugs and Reimbursement

Transparency, social change can help pharma regain the public’s trust

STAT+: Pharmalittle: We’re reading about Amgen suing Colorado over drug price caps, abortion pills, and more

Amid sector disruption, biotech must focus on 'fundamentals'

Biden and Trump are fighting to claim credit for $35 insulin. It was actually a pharma giant’s idea

Makary: Drugs don’t have to take 10 years to get to market

STAT+: Pharmalittle: We’re reading about Medicare plans to negotiate obesity-drug prices, a Novartis 340B lawsuit, and more

FDA clears Nuvation lung cancer drug, setting up battle with Bristol Myers and Roche

Stay Connected